Need to Know FDA Approves Pradaxa for Thromboprevention After Hip Replacement November 25, 2015 OrthoBuzz for Surgeons The FDA this week approved dabigatran (Pradaxa) for prevention of DVT and pulmonary embolism following hip arthroplasty surgery. The approval follows FDA analysis of two Read More
